封面
市場調查報告書
商品編碼
1671948

免疫組織化學市場按產品、應用、最終用戶和地區分類

Immunohistochemistry Market, By Product, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 142 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球免疫組織化學市場規模估計為 30.7 億美元,預計到 2032 年將達到 48.4 億美元,2025 年至 2032 年的複合年成長率為 6.7%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 30.7億美元
效能資料 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 6.70% 2032 年價值預測 48.4億美元
數字。 2025 年免疫組織化學市場佔有率(%),依地區分類
免疫組織化學市場-IMG1

免疫組織化學 (IHC) 是一種利用抗體特異性結合活組織中的抗原的原理來檢測組織切片細胞中的抗原的技術。 IHC 可以識別細胞類型和生物標記的位置以及正常和患病組織中標靶抗原的分佈,有助於疾病診斷、預後評估、預測醫學和個人化醫療。 IHC 利用抗體-抗原親和性在顯微鏡下觀察組織樣本中細胞內的特定蛋白質,有助於細胞類型辨識和生物分子定位。為了獲得準確、可重複的結果,必須嚴格控制所使用的細胞、抗原和抗體。

市場動態:

全球免疫組織化學市場主要受老年人口增加以及相關慢性病和感染疾病病率上升的推動。根據世界衛生組織(WHO)2022年10月的報告,2015年至2050年間,全球60歲及以上人口比例將成長近一倍,從12%增至22%。全球癌症發生率的不斷上升也推動了對 IHC 檢測的需求,以檢測與癌症診斷和預後相關的生物標記。然而,IHC 診斷試劑套件核准的嚴格法律規範和熟練人力的短缺(尤其是在新興國家)是限制市場成長的挑戰。數位病理學解決方案的出現提供了 IHC 染色的自動量化以及人工智慧的整合以實現更準確的分析,為市場參與者提供了有利可圖的機會。

本研究的主要特點

  • 本研究報告對全球免疫組織化學市場進行了詳細分析,並以 2024 年為基準年,給出了預測期(2025-2032)的市場規模和年複合成長率(CAGR%)。
  • 它揭示了不同領域的潛在收益成長機會,並解釋了該市場的引人注目的投資提案矩陣。
  • 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 全球免疫組織化學市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球免疫組織化學市場報告針對該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球免疫組織化學市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 市場機會
  • 影響分析
  • 管道分析
  • PEST分析
  • 監管情景
  • 市場趨勢
  • 主要亮點
  • 合併和收購

4. 全球免疫組織化學市場 - COVID-19 疫情的影響

  • 經濟影響
  • 對臨床試驗的影響
  • 政府舉措

5. 2020 年至 2032 年全球免疫組織化學市場(依產品分類)

  • 抗體
  • 一抗
  • 二抗
  • 試劑
  • 蛋白水解酶
  • 固定試劑
  • 組織學染色
  • 沖淡
  • 其他
  • 裝置
  • 玻片染色系統
  • 組織處理系統
  • 幻燈片掃描儀
  • 其他設備
  • 套件

6. 2020 年至 2032 年全球免疫組織化學市場(按應用分類)

  • 診斷
  • 癌症
  • 感染疾病
  • 自體免疫疾病
  • 神經系統疾病
  • 其他疾病
  • 研究
  • 其他

7. 2020 年至 2032 年全球免疫組織化學市場(依最終使用者分類)

  • 醫院
  • 診斷實驗室
  • 學術研究所
  • 其他

8. 2020 年至 2032 年全球免疫組織化學市場(按地區分類)

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • 熱圖分析
  • 市場佔有率分析
    • Merck KGaA
    • Rockland Immunochemical, Inc.
    • F. Hoffman-La Roche Ltd
    • Thermo Fisher Scientific
    • PerkinElmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Cell Signaling Technology, Inc.
    • Bio SB
    • Agilent Technologies, Inc.
    • Abcam plc.
    • Bectom, Dickson and Company
    • Miltenyi Biotec
    • Biocare Medical, LLC
    • Eagle Bioscience, Inc.
    • Bio Techne
    • Diagnostic Biosystems, Inc.
    • BioGenex

第 10 章 分析師觀點

  • 命運之輪
  • 分析師觀點
  • 一致的機會圖

第 11 章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4795

Global Immunohistochemistry Market is estimated to be valued at USD 3.07 Bn in 2025 and is expected to reach USD 4.84 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.07 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.70% 2032 Value Projection: USD 4.84 Bn
Figure. Immunohistochemistry Market Share (%), By Region 2025
Immunohistochemistry Market - IMG1

Immunohistochemistry (IHC) is a technique used to detect antigens in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues. IHC enables researchers to identify cell types and locations of biomarkers as well as the distribution of target antigens in normal and diseased tissues. It helps in disease diagnosis, prognostic evaluation, and predictive and personalized medicine. IHC uses affinity between antibodies and antigens for making specific proteins in cells of a tissue sample visible microscopically, thus aiding in the identification of cell type and localization of biomolecules. The cells, antigens, and antibodies used must be carefully controlled to ensure accurate and reproducible results.

Market Dynamics:

The global immunohistochemistry market is primarily driven by the rising geriatric population and associated increase in prevalence of chronic and infectious diseases. According to the World Health Organization (WHO) October 2022 report, the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. The growing incidence of cancer worldwide is also boosting the demand for IHC assays to detect biomarkers related to cancer diagnosis and prognosis. However, stringent regulatory frameworks for the approval of IHC diagnostic kits and lack of skilled personnel especially in developing nations are some challenges restraining the market growth. The emergence of digital pathology solutions offering automated quantification of IHC staining and integration of Artificial Intelligence for more accurate analysis present lucrative opportunities for market players.

Key Features of the Study:

  • This report provides an in-depth analysis of the global immunohistochemistry market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global immunohistochemistry market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck KGaA, Rockland Immunochemicals Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB, Agilent Technologies Inc., Abcam plc., Becton Dickinson and Company, Miltenyi Biotec, Biocare Medical LLC, Eagle Biosciences Inc., Bio-Techne, Diagnostic Biosystems Inc., and BioGenex.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global immunohistochemistry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunohistochemistry market.

Market Segmentation

  • Product:
    • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
    • Reagents
    • Proteolytic Enzymes
    • Fixation Reagents
    • Histological Stains
    • Diluents
    • Others
    • Equipment
    • Slide-staining systems
    • Tissue Processing Systems
    • Slide Scanners
    • Other Equipment
    • Kits
  • Application:
    • Diagnostics
    • Cancer
    • Infectious Diseases
    • Autoimmune Diseases
    • Neurological Diseases
    • Others Diseases
    • Research
    • Others
  • End User:
    • Hospitals
    • Diagnostics Laboratories
    • Academic & Research Institutes
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Merck KGaA
    • Rockland Immunochemicals Inc.
    • Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific
    • PerkinElmer Inc.
    • Bio-Rad Laboratories Inc.
    • Cell Signaling Technology Inc.
    • Bio SB
    • Agilent Technologies Inc.
    • Abcam plc.
    • Becton Dickinson and Company
    • Miltenyi Biotec
    • Biocare Medical LLC
    • Eagle Biosciences Inc.
    • Bio-Techne
    • Diagnostic Biosystems Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • PEST Analysis
  • Regulatory Scenario
  • Market Trends
  • Key Highlights
  • Mergers & Acquisitions

4. Global Immunohistochemistry Market - Impact of Coronavirus (COVID-19) Pandemic

  • Economic Impact
  • Impact on Clinical Trials
  • Government Initiatives

5. Global Immunohistochemistry Market, By Product Type, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Primary Antibodies
  • Secondary Antibodies
  • Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Proteolytic Enzymes
  • Fixation Reagents
  • Histological Stains
  • Diluents
  • Others
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Slide-staining systems
  • Tissue Processing Systems
  • Slide Scanners
  • Other Equipment
  • Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)

6. Global Immunohistochemistry Market, By Application, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Cancer
  • Infectious Diseases
  • Autoimmune Diseases
  • Neurological Diseases
  • Others Diseases
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)

7. Global Immunohistochemistry Market, By End User, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)

8. Global Immunohistochemistry Market, By Region, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2020-2032
  • North America
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD BN)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD BN)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD BN)
      • South Africa
      • Central Africa
      • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Merck KGaA
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Rockland Immunochemical, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • F. Hoffman-La Roche Ltd
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Thermo Fisher Scientific
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • PerkinElmer, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bio-Rad Laboratories, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Cell Signaling Technology, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bio SB
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Agilent Technologies, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Abcam plc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bectom, Dickson and Company
    • Miltenyi Biotec
    • Biocare Medical, LLC
    • Eagle Bioscience, Inc.
    • Bio Techne
    • Diagnostic Biosystems, Inc.
    • BioGenex

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact